-
The eve of the fifth batch of national procurement bids: In addition to "low-price selection", what other ways to survive for generic drugs?
Time of Update: 2021-07-28
Great environmental changes "Bring gold" to the end There is no need for academic promotion of generic drugs, because the original drugs have already or basically completed the education of the market .
-
Comparative analysis and diagnosis model establishment of membranous nephropathy and other types of nephropathy
Time of Update: 2021-07-28
The non-invasive diagnostic model established in this study through Logistic regression analysis can effectively diagnose membranous nephropathy with high sensitivity and specificity, and has a wide range of clinical application potential .
-
Notice on the solicitation of proposals for the establishment of the national drug standard improvement project in 2022
Time of Update: 2021-07-28
Pharmaceutical manufacturers, operating enterprises, user units, regulatory agencies, inspection institutions, scientific research institutes, and related social organizations and individuals, on the standards of approved drugs (including pharmaceutical excipients and packaging materials), and general technology in the Chinese Pharmacopoeia Those who require comments and suggestions for updates and improvements can be submitted to our committee in accordance with the requirements of the attached table .
-
Kangmei was exposed to bankruptcy and reorganization!
Time of Update: 2021-07-28
On the evening of May 11, Shanghai Pharmaceuticals issued an announcement stating that in order to support the company's long-term business development, improve the industrial layout, and further enhance the company's overall strength, the company plans to introduce Yunnan Baiyao as a strategic investor through this non-public issuance of A shares .
-
Hengrui's "Carrelizumab" new indication has been released!
Time of Update: 2021-07-28
The results of the study show that carrelizumab combined with chemotherapy for first-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer can significantly prolong the progression-free survival of patients .
-
Why did the CDKs family only succeed with CDK4/6 inhibitors?
Time of Update: 2021-07-28
In October 2017, Abesinil was approved for marketing in the United States, and its indications are single-agent or combined with fulvestrant for the second-line treatment of HR-positive/HER2-negative advanced metastatic breast cancer; FDA approved it again in February 2018 The drug is used in combination with aromatase inhibitors as the initial therapy of endocrine therapy for the treatment of postmenopausal women with HR-positive/HER2-negative advanced or metastatic breast cancer .
-
31 new confirmed cases and 5 local cases were confirmed on July 18
Time of Update: 2021-07-28
As of 24:00 on July 18, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 565 confirmed cases (including 13 severe cases), 87,076 cured and discharged cases, and 4,636 deaths.
-
Anti-monopoly heavy blows under control of sales are easy to "step on thunder"!
Time of Update: 2021-07-28
For example, in accordance with the "province-prefecture-county" model of sales control, a product has an ex-factory price of 10 yuan, and the retail price of a product sold to consumers is 57.
-
How does Guangdong control the epidemic?
Time of Update: 2021-07-28
How does Guangdong control the epidemic? How to deal with mutant viruses? Headquarters reporter in dialogue with Zhong Nanshan How does Guangdong control the epidemic? How to deal w
-
A week of drug resumption (6.7-6.11)
Time of Update: 2021-07-28
2. On June 8th, BeiGene announced that CDE had accepted its anti-PD-1 tislelizumab injection (trade name: Beizean) for the treatment of previously treated, locally advanced unresectable or metastatic disease New indications for patients with high degree of microsatellite instability (MSI-H) or defective mismatch repair (dMMR) solid tumors .
-
Zhong Nanshan: Artificial Intelligence "Breaking Out" Helping Epidemic Prevention and Control
Time of Update: 2021-07-28
Zhong Nanshan said that the new generation of information technology such as artificial intelligence has empowered the medical, health, and public health fields, promoted the global basic medical research, clinical application research, and the research and development of pharmaceutical devices, and further enhanced human cognition and understanding of diseases .
-
Health Commission: 25 newly diagnosed cases on the 25th, all imported from abroad
Time of Update: 2021-07-28
As of 24:00 on June 25, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 474 confirmed cases (including 14 severe cases), a total of 86,608 cured and discharged cases, and a total of 4,636 deaths.
-
The data said: The second round of centralized procurement was implemented for one year, what impact did it bring to the market, and why did the volume and price of generic drugs fall?
Time of Update: 2021-07-28
Using the sales data analysis in 2020 (refer to the admission price of IMS), the total sales of more than 30 varieties selected in the second round of centralized procurement will be 29.
503 billion doses, and the total sales of generic drugs fell from 18.
-
Ultra-thin spinal implants can help treat stubborn pain
Time of Update: 2021-07-28
According to a paper recently published in the journal "Science Advances", researchers at the University of Cambridge in the United Kingdom combined soft robotics manufacturing technology, ultra-thin electronics and microfluidic technology to develop an ultra-thin inflatable device that can treat the most severe limb pain , Such as leg and back pain that cannot be cured by painkillers, without the need for invasive surgery .
-
The price fight is tragic!
Time of Update: 2021-07-28
In this centralized procurement, 3 billion large varieties of oxaliplatin injection (50 mg/bottle) were selected in the bidding for 4 companies, namely Hengrui (91.
For example, Kelun Pharmaceutical, the main injection company, has selected all of the 11 centralized procurement products this time .
-
"Vegetarian" soft capsules that can replace gelatin have appeared!
Time of Update: 2021-07-28
In order to make SeaGel®, we purify carrageenan and use it as a dry powder in SeaGel®CAP 101 to provide better formulation flexibility, or further blend with starch to produce SeaGel®CAP 201, CAP 202 and CAP 203, which helps Manufacturers have significantly improved production efficiency .
-
Delicious food hides "three highs" risks
Time of Update: 2021-07-28
Xu Jiao, director of the Food and Nutrition Division of the Food Safety Standards and Monitoring and Evaluation Department of the National Health Commission, said that high salt, high oil, and high sugar intake are risk factors for obesity, cardiovascular and cerebrovascular diseases, diabetes and other metabolic diseases and cancer.
-
Bicar® Pharma is registered and activated in the Drug Evaluation Center of the National Medical Products Administration as an API
Time of Update: 2021-07-28
Shanghai, 2021 Nian 4 Yue 22 Ri Solvay's pharmaceutical grade Bicar® Pharma Sodium Bicarbonate was successfully registered and activated in the Center for Drug Evaluation ( CDE ) of the National Medical Products Administration ( NMPA ) in November 2020 .
-
The adjustment of the medical insurance catalogue starts!
Time of Update: 2021-07-28
In the expert review stage, the National Medical Insurance Bureau will demonstrate the expert opinions of the professional group, and finally determine the list of drugs in five aspects: direct transfer, negotiation transfer, direct transfer, can transfer, and adjust the limited payment scope .
-
Zhong Nanshan talks about mutant virus strains: the establishment of an immune barrier is imminent
Time of Update: 2021-07-28
"This time, due to the high viral load and highly infectious characteristics of the delta strain, as long as the patient was in the same space, unit, and building 4 days before the onset of illness, they were considered close contacts .
